Shanghai Fosun Pharmaceutical Announces AGM with Key Resolutions

Confident Investing Starts Here:

Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) has issued an announcement.

Shanghai Fosun Pharmaceutical has announced its annual general meeting scheduled for June 24, 2025, where shareholders will consider various resolutions including the approval of the 2024 annual report, profit distribution proposal, and re-appointment of auditors. The meeting will also address the authorization of management to dispose of shares, amendments to management systems, and the issuance of corporate bonds, which could impact the company’s financial strategies and governance structure.

More about Shanghai Fosun Pharmaceutical (Group) Co

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company incorporated in China, operating in the pharmaceutical industry. The company focuses on the development, manufacturing, and distribution of pharmaceutical products and services, catering to both domestic and international markets.

Average Trading Volume: 5,143,571

Technical Sentiment Signal: Sell

Current Market Cap: HK$62.5B

See more data about 2196 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

No Byline Policy

Editorial Guidelines

Corrections Policy

Source